Bamco Inc. NY boosted its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN) by 309.6% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 106,654 shares of the medical equipment provider’s stock after purchasing an additional 80,614 shares during the quarter. Bamco Inc. NY owned about 0.13% of Align Technology worth $16,011,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in ALGN. American Century Companies Inc. raised its stake in Align Technology by 16.5% during the first quarter. American Century Companies Inc. now owns 9,461 shares of the medical equipment provider’s stock valued at $1,085,000 after purchasing an additional 1,337 shares in the last quarter. UBS Asset Management Americas Inc. raised its stake in Align Technology by 40.5% during the first quarter. UBS Asset Management Americas Inc. now owns 182,595 shares of the medical equipment provider’s stock valued at $20,945,000 after purchasing an additional 52,601 shares in the last quarter. Neuberger Berman Group LLC raised its stake in Align Technology by 11.7% during the first quarter. Neuberger Berman Group LLC now owns 4,538 shares of the medical equipment provider’s stock valued at $521,000 after purchasing an additional 474 shares in the last quarter. BB&T Securities LLC purchased a new stake in Align Technology during the first quarter valued at $305,000. Finally, Credit Agricole S A raised its stake in Align Technology by 46.1% during the first quarter. Credit Agricole S A now owns 57,174 shares of the medical equipment provider’s stock valued at $6,558,000 after purchasing an additional 18,029 shares in the last quarter. 81.57% of the stock is currently owned by institutional investors.

Shares of Align Technology, Inc. (NASDAQ ALGN) opened at 186.27 on Friday. The stock has a 50 day moving average of $176.23 and a 200 day moving average of $145.25. Align Technology, Inc. has a 52 week low of $83.27 and a 52 week high of $190.04. The stock has a market cap of $14.93 billion, a P/E ratio of 63.79 and a beta of 1.55.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.73 by $0.12. The firm had revenue of $356.50 million for the quarter, compared to analysts’ expectations of $343.43 million. Align Technology had a net margin of 19.18% and a return on equity of 23.87%. The company’s revenue was up 32.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.62 EPS. On average, analysts expect that Align Technology, Inc. will post $3.40 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This report was originally posted by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://www.watchlistnews.com/bamco-inc-ny-acquires-80614-shares-of-align-technology-inc-algn/1601175.html.

A number of equities research analysts recently issued reports on the stock. Stifel Nicolaus reaffirmed a “buy” rating and set a $205.00 price target (up previously from $200.00) on shares of Align Technology in a research note on Monday, August 7th. Goldman Sachs Group, Inc. (The) increased their target price on shares of Align Technology from $185.00 to $210.00 and gave the company a “buy” rating in a research note on Friday, September 15th. Robert W. Baird reissued a “buy” rating on shares of Align Technology in a research note on Tuesday, September 12th. Bank of America Corporation raised shares of Align Technology from a “neutral” rating to a “buy” rating and increased their target price for the company from $175.00 to $193.00 in a research note on Friday, July 28th. Finally, Leerink Swann reissued an “outperform” rating and issued a $199.00 target price (up previously from $194.00) on shares of Align Technology in a research note on Friday, July 28th. One research analyst has rated the stock with a hold rating and ten have issued a buy rating to the stock. Align Technology presently has an average rating of “Buy” and an average target price of $179.82.

Align Technology Company Profile

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.